Los mejores podcasts de Real Chemistry (2024)

1
Health Citizenship and the Evolution of Technology and Healthcare: Jane Sarasohn-Kahn, Health Economist 41:16

2M ago41:16

41:16

A health economist, blogger, two-time author, and keynote speaker, Jane Sarasohn-Kahn is a renowned leader in the healthcare space. On this episode, she discusses health citizenship, its potential impact on the upcoming election, the continuous evolution of technology and healthcare, and what she’s most looking forward to in the future.…

1
Embracing the Power of RNAi Therapeutics: Akshay Vaishnaw, Alnylam Pharmaceuticals 35:37

4M ago35:37

35:37

Discover the cutting-edge world of RNA interference (RNAi) therapeutics with Dr. Akshay Vaishnaw, Chief Innovation Officer at Alnylam Pharmaceuticals. In this episode, Dr. Vaishnaw sheds light on the groundbreaking concept of RNAi therapeutics, offering a powerful new approach to treating a wide range of diseases. Learn how Alnylam Pharmaceuticals …

1
Cannesplaining Healthcare: Creating Award-Worthy Work through Insight and Originality 39:00

5M ago39:00

39:00

Want to know what it takes to create award-winning work in healthcare advertising? Check out our final Cannesplaining Healthcare podcast episode, live from the 2024 Cannes Lions International Festival of Creativity, featuring our 21GRAMS, a part of Real Chemistry, creative leaders as they explore the intersection of creativity, marketing and health…

1
Cannesplaining Healthcare: Emphasizing the Importance of Creativity in Healthcare with Genentech Chief Marketing Officer, Dr. Erica Taylor 40:45

5M ago40:45

40:45

Live from the 2024 Cannes Lions International Festival of Creativity, join us as we explore the intersection of creativity, marketing and healthcare during our latest Cannesplaining Healthcare podcast episode featuring Genentech Chief Marketing Officer (CMO) Dr. Erica Taylor, 21GRAMS Managing Founder & Real Chemistry Chief Creative Officer Frank Ma…

1
Cannesplaining Healthcare: Improving Patient Experiences Through Creativity & Innovation With President of Cannes Lions 2024 Pharma Jury, Collette Douaihy 30:07

5M ago30:07

30:07

Live from the 2024 Cannes Lions International Festival of Creativity, join us for a discussion on the future of healthcare innovation and creativity. In this episode, Collette Douaihy, Dentsu Health Global CCO and President of Cannes Lions 2024 Pharma Jury, 21GRAMS Global CCO Tom Richards and 21GRAMS Executive Creative Director Chris Charles delve …

1
The Art & Science of Cancer Care: A Holistic Approach 44:25

6M ago44:25

44:25

In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year’s meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and f…

1
Fighting Health Worker Burnout with Privacy-Safe AI: Live from SXSW 2024 43:50

7M ago43:50

43:50

Health worker burnout is soaring. A global shortage of providers, an aging population and more complicated Medicare requirements, has increased stress and exhaustion for HCPs. Innovative solutions are needed to ensure high-quality patient care and a sustainable health system. This panel will discuss how AI is helping alleviate pressure on providers…

1
Cancer 2034: Innovations That Are Shaping the Face of Cancer - Live from SXSW 2024 44:53

8M ago44:53

44:53

With innovative new approaches to diagnosis and treatment in oncology, the cancer mortality rate has dropped year over year for the last decade. But there is still work to be done, especially as we see increasing cancer incidence among certain populations. But what work is happening today that will shape the face of cancer and the patient experienc…

1
Partnering to Unlock Hope for the Future of Cancer Care: Live from SXSW 2024 41:54

8M ago41:54

41:54

While there is undeniable hope for the future of cancer care, systemic barriers still impact access for many patients – particularly those in underserved communities. This session, originally recorded in front of a live audience at SXSW 2024, examines how increasing collaboration and partnerships among organizations that touch all aspects of the ca…

1
Advancing Medical Communications by Combining Data, Creativity and Human Expertise: Suzanne Jacobs, Real Chemistry & Trina Stonner, Avant Healthcare 29:31

10M ago29:31

29:31

In this episode, Suzanne Jacobs, Group President of Medical at Real Chemistry, and Trina Stonner, President of Avant Healthcare, discuss Real Chemistry’s newly announced acquisition of Avant Healthcare, how the two companies came together and have similar ethos of supporting physicians in advancing patient care, and how the future of medical commun…

1
Caregiving and Cancer Prevention: Dr. Karen Knudsen, The American Cancer Society & Jim Weiss, Real Chemistry 37:19

12M ago37:19

37:19

It's time to talk about cancer prevention and early detection. Join us as we explore the importance of early detection and prevention in the fight against cancer with Dr. Karen Knudsen, CEO of the American Cancer Society, and Jim Weiss, Founder and Chairman at Real Chemistry. Tune in to learn about the role of the American Cancer Society in researc…

1
Using Generative AI to Bring New Perspectives to Medical Problem Solving: Peter Lee, Microsoft & Brandon Pletsch, Real Chemistry 45:08

12M ago45:08

45:08

Listen to our latest podcast with Peter Lee, Corporate Vice President, Microsoft Research & Incubations, and Brandon Pletsch, Practice Leader of Scientific Visualization at Real Chemistry, to learn about the applications and implications of generative AI, specifically GPT-4, in healthcare and other fields. They explore public perceptions of AI, its…

1
Enhancing Healthcare Consistency Through AI: Ajit Singh, Artiman Ventures 40:58

1y ago40:58

40:58

In this episode, Ajit Singh, PhD, Managing Director and General Partner at Artiman Ventures, shares his insights on various aspects of healthcare, his approach to leadership and decision-making and his thoughts on the future of healthcare. From AI to oncology to neuro technology, Ajit covers it all.Por Real Chemistry

1
Reshaping the Medical Communications World through AI: Jason Gardner, SVP, Head of Medical, Real Chemistry 20:57

1y ago20:57

20:57

Learn more about the inspiring journey of Jason Gardner, Head of Medical at Real Chemistry, and his views on AI and DE&I in healthcare. From his father's struggle with multiple sclerosis to his strategic approach to medical communications, Jason shares his unique perspectives on how diverse thinking and experiences can bring value to the healthcare…

1
Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council 47:55

1y ago47:55

47:55

In this episode, National Pharmaceutical Council (NPC) President and CEO John O'Brien, PharmD, MPH, joins Real Chemistry’s Founder and Chairman, Jim Weiss, to discuss the pharmaceutical industry, the value assessment of medicines, the role of government in drug pricing and the importance of research in healthcare policy. Tune in to get the latest i…

1
Tackling Health Disinformation in the AI and Digital Age: Dr. Geeta Nayyar, Author, Dead Wrong 27:08

1y ago27:08

27:08

Misinformation in the digital age is a complex problem, but it can be addressed. In this episode, Dr. Geeta Nayyar, former Chief Medical Officer at Salesforce and AT&T, discusses her book, Dead Wrong, and the role of artificial intelligence in healthcare. Tune in to learn more about the importance of trust in the healthcare industry, the role of li…

1
Valuing Empathy to Ensure Patient-Centered Healthcare Strategies: Javeria Shahab, 21GRAMS, a part of Real Chemistry 31:32

1y ago31:32

31:32

In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to brea…

1
Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Council of Advisors on Science and Technology 55:24

1y ago55:24

55:24

In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, …

1
Pioneering Public-Private Partnerships to Tackle Complex Health Issues: Dr. Julie Gerberding, FNIH, Dr. Jay Bradner, FNIH & Jim Weiss, Real Chemistry 55:09

1+ y ago55:09

55:09

In this episode, Dr. Julie Gerberding, President and CEO of the Foundation for the National Institutes of Health (FNIH), Dr. Jay Bradner, FNIH board member and former President of the Novartis Institutes for Biomedical Research, and Jim Weiss, Founder and Chairman at Real Chemistry and FNIH board member, discuss the power of collaboration, how trus…

1
Analyzing the Impact of Data and Technology on Healthcare Commercialization: Mark Martin, Houlihan Lokey & Jim Weiss, Real Chemistry 37:46

1+ y ago37:46

37:46

In this episode, Mark Martin, Managing Director at Houlihan Lokey, and Jim Weiss, Founder and Chairman at Real Chemistry, explore the healthcare marketing and commercialization industry, including the impact of data and technology, trends in acquisitions and deals, and the importance of organic growth and innovation.…

1
Developing Innovative Digital Medicine Solutions that Address Real Pain Points: Jennifer Goldsack, Digital Medicine Society 40:16

1+ y ago40:16

40:16

Digital medicine is essential for improving healthcare and addressing issues related to access and equity. In the latest episode, learn about the importance of digital medicine, the challenges and opportunities in the industry and the importance of an integrated evidence plan. Plus, CEO and Co-Founder of the Digital Medicine Society (DiMe), Jennife…

1
Addressing Liver Health through Collaboration and Innovation: Donna Cryer, Global Liver Institute 32:37

1+ y ago32:37

32:37

Did you know that there are more than 100 types of liver diseases that affect 1.5 billion people worldwide? Join us as we explore the importance of collaboration and innovation in addressing liver health issues, the role of digital health and equity, and the future of liver health with Donna Cryer, J.D., Founder, President and CEO of the Global Liv…

1
Exploring Space as the Next Frontier for Biopharma R&D: Maureen Haverty, Seraphim Space/Generation Space 29:53

1+ y ago29:53

29:53

Space exploration and research are rapidly advancing, and life sciences is a key component of this progress. Learn more about the opportunities and developments in space R&D and manufacturing, particularly in the life sciences sector, from Maureen Haverty, VP of Investment at Seraphim Space/Generation Space.…

1
Transforming How Patients Manage Chronic Conditions: Waqaas Al-Siddiq, Biotricity 25:45

1+ y ago25:45

25:45

In this episode with Biotricity CEO and Founder Waqaas Al-Siddiq, PhD, discover how AI is transforming healthcare and how Biotricity's Bioheart device is helping to manage and prevent cardiac conditions.Por Real Chemistry

1
Using Effective Communication to Build Strong Bridges: Sally Susman, Pfizer & Jim Weiss, Real Chemistry 49:11

1+ y ago49:11

49:11

Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and …

1
Delivering Personalized Care for Chronic Health Conditions: Live from SXSW 2023 with Lee Shapiro 27:31

1+ y ago27:31

27:31

Recorded live from SXSW 2023, 7wire Ventures Co-Founder & Managing Partner Lee Shapiro explores how technology, data and collaboration can be used to make healthcare more personalized, efficient and cost-effective, ultimately leading to improved health outcomes.Por Real Chemistry

1
Generative AI: Oh God What Now?: Live from SXSW 2023 33:49

1+ y ago33:49

33:49

With tools like ChatGPT and DALL-E dominating news cycles, many people – especially those working in creative jobs – are wondering if they will soon be replaced by the technology known as generative AI. During this session, originally recorded in front of a live audience at SXSW 2023, Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and…

1
Becoming a Change Agent through Impactful Disruption: Live from SXSW 2023 with GSK’s Alison Woo 26:11

1+ y ago26:11

26:11

Recorded live from SXSW 2023, Alison Woo, Head of Strategy, Planning and Paid Campaigns, Communications & Government Affairs at GSK, shares what a day in her life looks like, what she gathered at SXSW this year and what it means to be disruptive at a company without being too disruptive.Por Real Chemistry

1
A Day in the Life of a Biopharmaceutical Leader: Live from SXSW 2023 42:12

1+ y ago42:12

42:12

This presentation, originally recorded in front of a live audience at SXSW 2023, showcases key stories and perspectives on what a day in the life of a leader at Bristol-Myers Squibb looks like. From their experiences and challenges to how their focus on patients drives them to continue to strive in their role during these truly complicated times. P…

1
Innovating Data Approaches for Clinical Trial Recruitment: Live from SXSW 2023 47:15

1+ y ago47:15

47:15

This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidate…

1
Understanding Trends to Shape our Future Normal: Rohit Bhargava, Founder & Chief Trend Curator, Non-Obvious Company 28:52

1+ y ago28:52

28:52

Recorded live from SXSW 2023, Founder & Chief Trend Curator of the Non-Obvious Company Rohit Bhargava joins us to discuss why he continues to come back to SXSW, how the event has evolved and his new book co-authored with Henry Coutinho-Mason, The Future Normal, which leans into healthcare trends.Por Real Chemistry

1
Changing the Relationship of Underserved Populations with Clinical Trials: Dr. Keolu Fox, Co-Founder, Native BioData Consortium & Assistant Professor, University of California, San Diego 34:24

1+ y ago34:24

34:24

Indigenous futurist and technologist Dr. Keolu Fox joins us this week to discuss how increased diversity in clinical trials can transform healthcare for underserved populations and for the overall healthcare system.Por Real Chemistry

1
Building a Community of Caregivers: Andrew Parker, CEO & Founder, Papa 33:24

2y ago33:24

33:24

This week, CEO & Founder of Papa Andrew Parker joins the podcast and discusses how his company is empowering a new kind of healthcare built on human connection. Papa, a platform that connects older adults with Pals who provide companionship and assistance, seeks to address the caregiving shortage and support the US healthcare system’s Triple Aim.…

1
Addressing a New Wave of Healthcare Challenges: Annalisa Jenkins, Compass Pathways & Jim Weiss, Real Chemistry 38:35

2y ago38:35

38:35

Annalisa Jenkins, MBBS, Non Executive Director at Compass Pathways & Jim Weiss, Founder and Chairman at Real Chemistry, join the podcast this week to discuss women in life sciences leadership roles, novel approaches to disease areas such as infectious diseases and cancer, and using AI for a more effective healthcare system.…

1
Breaking Down Healthcare Industry Barriers: Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine, University of Oxford & Jim Weiss, Founder & CEO, Real Chemistry ... 36:34

2y ago36:34

36:34

Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine at the University of Oxford, and Jim Weiss, Founder & CEO of Real Chemistry, join this week’s episode to discuss accelerating healthcare through novel ideas and the importance of collaborating across organizations, industries and countries.…

1
Democratizing Access to Healthcare: Pranam Ben, Founder & CEO, The Garage 28:23

2y ago28:23

28:23

Founder and CEO of The Garage, Pranam Ben, joins us to discuss the future of value-based care and The Garage’s approach of using technology and data to solve for equity and access issues facing the healthcare industry. Read The Garage’s blog post, Tiny Tasty Morsels, to learn about their Quintuple Aim approach to change healthcare for good.…

1
Building the Future of HEOR: Christopher Boone, PhD, VP & Global Head of HEOR, AbbVie 29:23

2y ago29:23

29:23

In this week’s episode, Christopher Boone, PhD, VP & Global Head of Health Economic Outcomes and Research (HEOR) at AbbVie, discusses the changing landscape of HEOR, the importance of leadership, collaboration and innovation in the pharmaceutical industry, and the story behind his Twitter handle, DataHippie.…

1
Improving Patient Care through Better Data Interoperability: Frank Harvey, CEO, Surescripts 18:18

2y ago18:18

18:18

In this week’s episode, Surescripts CEO Frank Harvey discusses how Surescripts is improving healthcare data interoperability and better empowering pharmacists to provide primary care to patients.Por Real Chemistry

1
Harnessing the Human Approach: Harpreet Sood, MD, VP, Primary Care & Clinical Partnerships, Huma 25:48

2y ago25:48

25:48

Huma VP of Primary Care & Clinical Partnerships Harpreet Sood, MD discusses shifts in the digital health market and how Huma differentiates itself through a focus on patient centricity and collaboration across healthcare systems and teams.Por Real Chemistry

1
Simplifying Medicine with Technology: Matt Titus, VP & Chief Commercial Officer, epocrates 21:28

2y ago21:28

21:28

Data and technology should make physicians’ lives simpler, not more complicated. Matt Titus, VP & Chief Commercial Officer, epocrates, shares how his team is making an impact.Por Real Chemistry

1
Advocating for Patients: Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author 16:01

2y ago16:01

16:01

Working toward creating better patient outcomes and experiences is something we have in common with Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author.Por Real Chemistry

1
Assessing the State of COVID-19: Monica Gandhi MD, MPH, Professor of Medicine, UCSF 32:25

2y ago32:25

32:25

The doctor will see you now! Monica Gandhi, MD, MPH, Professor of Medicine, UCSF, is back on the show, and she’s talking about all things COVID-19, flu, and vaccines.Por Real Chemistry

1
Investing in Marketing & Analytics: Mark Stouse, Chairman & CEO, Proof 27:22

2y ago27:22

27:22

Investing in marketing and analytics is critical to navigating your organization successfully. Mark Stouse, Chairman & CEO of Proof, and Jim Weiss, Founder & Chairman of Real Chemistry, join the show to discuss this and the current state of marketing.Por Real Chemistry

1
Advancing Health Equity: Mary Stutts, Chief Global Health Equity & Inclusion Officer, Real Chemistry 31:15

2y ago31:15

31:15

Mary Stutts, Real Chemistry’s Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.Por Real Chemistry

1
Addressing Aging: Juliette Han, PhD, COO & CFO, Cambrian BioPharma 34:15

2y ago34:15

34:15

Addressing aging is a challenge that our client Juliette Han, PhD, COO and CFO of Cambrian BioPharma, welcomes because it's universal. Learn how Dr. Han and her team are aiming to increase "healthspan."Por Real Chemistry

1
Accelerating the American Cancer Society’s Mission: Alice Lin Pomponio, Managing Director, BrightEdge Fund 38:34

2y ago38:34

38:34

This week’s guest is dedicated to accelerating the American Cancer Society’s (ACS) mission. Alice Lin Pomponio joins the show to discuss how the BrightEdge Fund accelerates the ACS’ goal to reduce cancer mortality, end pain and suffering, and advance health equity. Plus, she shares her love of a hit Broadway musical.…

1
Accelerating Diversity & Inclusion: Marcus Sawyerr, Founder & CEO, EQ Community 34:23

2y ago34:23

34:23

Marcus Sawyerr, Founder & CEO of EQ Community, rejoins the show, but a lot has changed since the last time we spoke, like his mission to accelerate diversity and inclusion. And some things have remained the same, like his appreciation of JAY-Z.Por Real Chemistry

1
Revolutionizing Neurodiagnostics and Brain Therapeutics: Mary Lou Jepsen, Ph.D., CEO & Founder, Openwater 39:43

2+ y ago39:43

39:43

Inventor, trailblazer and one of the 100 most influential people in the world, according to TIME Magazine, Mary Lou Jepsen, Ph.D., joins the show. She shares how her company, Openwater, is changing the game in neurotherapeutics and why she'd want a record player on a deserted island. Learn more about this incredible work via Dr. Jepsen’s Life Itsel…

1
Keeping the Biomedical Innovation System Humming: Peter Kolchinsky, Ph.D., Biotech Investor, Scientist & Author 22:58

2+ y ago22:58

22:58

Biotech investor, scientist and author Peter Kolchinsky, Ph.D. joins the show with our Founder and Chairman, Jim Weiss, to discuss what the passing of the Prescription Drug Pricing Reform bill would mean for our industry.Por Real Chemistry

1
Making Health Care Approachable: Dr. Geeta Nayyar, Chief Medical Officer, Salesforce 18:16

2+ y ago18:16

18:16

Making health information more approachable, simple and easy to understand will improve health literacy and ultimately improve patient outcomes. Dr. Geeta Nayyar, Chief Medical Officer of Salesforce, joins the show to discuss health misinformation and her takeaways from the Life Itself conference, plus she shares her love of U2.…

Podcasts que vale la pena escuchar

Podcasts de Real Chemistry

Podcasts que vale la pena escuchar

Guia de referencia rapida